Immunosuppressive Therapy for PAH in Connective Tissue Diseases
Immunosuppressive therapy has emerged as a pivotal approach in managing pulmonary arterial hypertension (PAH), particularly in patients afflicted with connective tissue diseases (CTDs). The recent...